Interrad Medical Inc.
This article was originally published in Start Up
Venous access catheters are held in place on the skin's surface with sutures, tape, or adhesive-backed catheter stabilization devices. None of these attachment methods are ideal: catheters frequently dislodge, requiring reinsertion from trained staff. Bacteria that accumulate on the skin under a sutured-down catheter hub or in tacky adhesives are a primary culprit in catheter-related bacterial infections. Interrad Medical aims to address these shortcomings with a subcutaneous catheter securement system, which anchors catheters in the fatty layer just beneath the surface of the skin.
You may also be interested in...
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, "Antibody Start-Ups," features profiles of 4-Antibody, Anaptys Biosciences and f-star. Plus these Start-Ups Across Health Care: Actuality Medical, INBONE Technologies, Interrad Medical and Tethys BioScience.
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.